<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03286101</url>
  </required_header>
  <id_info>
    <org_study_id>RD2017-01</org_study_id>
    <nct_id>NCT03286101</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled Clinical Trial On The Efficacy And Safety Of Topical 0.5% Ivermectin Lotion For The Treatment Of Head Lice Infestation Among Filipino Children Age 3 Years Or Older</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United Laboratories</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, placebo-controlled clinical study evaluating the efficacy
      and safety of a single application of 0.5% ivermectin lotion in Filipino subjects with head
      lice.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 14, 2017</start_date>
  <completion_date type="Actual">November 9, 2017</completion_date>
  <primary_completion_date type="Actual">October 12, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants cured of head lice infestation from their assigned product on day 2, day 8 and day 15 after the first treatment.</measure>
    <time_frame>Day 2 to day 15 after product application</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Pediculosis Capitis</condition>
  <arm_group>
    <arm_group_label>0.5% Ivermectin Lotion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5% Ivermectin lotion</intervention_name>
    <description>The intervention is composed of a single application of the 0.5% ivermectin lotion.</description>
    <arm_group_label>0.5% Ivermectin Lotion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vehicle</intervention_name>
    <description>The intervention is composed of a single application of the vehicle control.</description>
    <arm_group_label>Vehicle control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Index subjects must have an active lice infestation defined as: At least 3 live lice
             (adult and/or nymphs) present on the scalp and/or hair as determined by a trained
             evaluator; After the index subject has been enrolled, additional infested household
             members will be enrolled.

          -  Household subjects must have an active head lice infestation defined as: At least 1
             live louse (adult and /or nymph) present on the scalp and/or hair, as determined by a
             trained evaluator (with the exception of the male head of household who may self-
             assess, as being lice free).

          -  Subject is male or female;

          -  Subject is at least 3 years old or older at the time of enrollment;

          -  Subject is in good general health based on the medical history;

          -  Each adult subject must have an appropriately signed Informed Consent agreement. For
             children, parents/guardian must sign an Informed Parental Consent agreement for
             children not old enough to do so. Children of a specified age will be administered a
             child's assent form

          -  The caregiver of a subject must be willing to allow all household members to be
             screened for head lice. If other household members are found to have an active head
             lice infestation, they must be willing and able to participate in the study. No more
             than one working male per household maybe excluded from evaluation if he is assessed
             as being lice free by himself or the caregiver and cannot come in due to his work
             schedule. If this individual may have lice, he must come to the test facility,
             otherwise the entire household will be excluded from study participation.

          -  Subject and/or caregiver must be physically able and willing to report to the testing
             center for the supervised application of the product.

          -  Subjects agrees not to use any other form of lice treatment (commercial or
             mechanical/manual) while participating in the study;

          -  Following application and rinsing of the test product, subject agrees not to shampoo /
             wash, or rinse their hair or scalp until the 24-hour post treatment evaluation has
             been completed;

          -  Subject agrees to not cut or chemically treat their hair while participating in the
             study;

          -  Subject agrees to follow all study instructions.

        Exclusion Criteria:

          -  History of irritation or sensitivity to ivermectin or lotion components pediculosis or
             hair care products;

          -  Presence of visible skin / scalp conditions that are not attributable to head lice
             infestation, such as erythema, blisters, vesicles which in the opinion of the
             investigative personnel will interfere with safety and / or efficacy evaluations;

          -  Subjects suffering from psoriasis, atopic dermatitis or other conditions, which in the
             opinion of the investigator may compromise the objective of the study;

          -  Treatment for head lice (OTC, home remedy or Rx) in the last 14 days;

          -  Subjects under treatment which in the opinion of the investigator will interfere with
             the study results;

          -  Subjects who participated in a previous investigational drug study within the past 30
             days;

          -  Subjects who does not understand the requirements for the study participation and/ or
             likely exhibit poor compliance, in the opinion of the investigator;

          -  Females who are pregnant or lactating.

          -  Living in a household where at least one member is pregnant, lactating, or planning a
             pregnancy

          -  Subjects with skin lesions, specifically skin breaks are excluded because of possible
             absorption of the drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gertrude Chan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Trial Management and Testing Associates, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Trial Management and Testing Associates, Inc.</name>
      <address>
        <city>Muntinlupa</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Philippines</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2017</study_first_submitted>
  <study_first_submitted_qc>September 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2017</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parasitic Diseases</mesh_term>
    <mesh_term>Lice Infestations</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ivermectin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

